Jane Kennet

6.7k total citations
8 papers, 103 citations indexed

About

Jane Kennet is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Jane Kennet has authored 8 papers receiving a total of 103 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Physiology. Recurrent topics in Jane Kennet's work include Diabetes and associated disorders (5 papers), Diabetes Treatment and Management (2 papers) and T-cell and B-cell Immunology (2 papers). Jane Kennet is often cited by papers focused on Diabetes and associated disorders (5 papers), Diabetes Treatment and Management (2 papers) and T-cell and B-cell Immunology (2 papers). Jane Kennet collaborates with scholars based in United Kingdom, United States and Singapore. Jane Kennet's co-authors include John A. Todd, Linda S. Wicker, Frank Waldron-Lynch, Lucy Truman, Marcin Ł. Pękalski, Simon Bond, Adrian Mander, Mark L. Evans, Neil Walker and Ravinder Atkar and has published in prestigious journals such as Nature Communications, Diabetes and BMJ Open.

In The Last Decade

Jane Kennet

8 papers receiving 101 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Kennet United Kingdom 6 50 38 32 30 11 8 103
Kristýna Böhmová Czechia 4 45 0.9× 47 1.2× 19 0.6× 30 1.0× 8 0.7× 6 79
Alexandra Florescu Canada 6 38 0.8× 9 0.2× 11 0.3× 15 0.5× 16 1.5× 8 106
Mohammad Alhadj Ali United Kingdom 6 17 0.3× 30 0.8× 28 0.9× 29 1.0× 6 0.5× 13 72
Amandine Benoit France 7 25 0.5× 21 0.6× 36 1.1× 12 0.4× 15 1.4× 12 106
Clara Domingo‐Vila United Kingdom 5 19 0.4× 53 1.4× 33 1.0× 47 1.6× 6 0.5× 7 68
Alexander Hellesen Norway 6 38 0.8× 35 0.9× 79 2.5× 6 0.2× 10 0.9× 11 112
Jason Schairer United States 6 10 0.2× 38 1.0× 21 0.7× 15 0.5× 13 1.2× 12 96
Rosa Maria Neme Brazil 9 60 1.2× 37 1.0× 9 0.3× 48 1.6× 12 1.1× 22 329
Maria Somali Greece 6 11 0.2× 13 0.3× 75 2.3× 22 0.7× 6 0.5× 10 104
Yu Kusaka Japan 2 22 0.4× 8 0.2× 11 0.3× 14 0.5× 33 3.0× 2 80

Countries citing papers authored by Jane Kennet

Since Specialization
Citations

This map shows the geographic impact of Jane Kennet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Kennet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Kennet more than expected).

Fields of papers citing papers by Jane Kennet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Kennet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Kennet. The network helps show where Jane Kennet may publish in the future.

Co-authorship network of co-authors of Jane Kennet

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Kennet. A scholar is included among the top collaborators of Jane Kennet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Kennet. Jane Kennet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Golubić, Rajna, Jane Kennet, Victoria Parker, et al.. (2024). Dual glucagon‐like peptide ‐1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity. Diabetes Obesity and Metabolism. 26(7). 2634–2644. 9 indexed citations
2.
Tuong, Zewen Kelvin, Tian Zhao, Andrew P. Stewart, et al.. (2023). Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells. Nature Communications. 14(1). 2071–2071. 23 indexed citations
3.
Hamey, Fiona, Dominik Trzupek, Lee M, et al.. (2023). Low-dose IL-2 reduces IL-21(+) T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. Yearbook of pediatric endocrinology. 1 indexed citations
4.
Zhang, Jiayuan, Fiona Hamey, Dominik Trzupek, et al.. (2022). Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. Nature Communications. 13(1). 7324–7324. 18 indexed citations
6.
Seelig, Eleonora, Linsey Porter, Lucy Truman, et al.. (2018). The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes. JCI Insight. 3(19). 29 indexed citations
8.
Truman, Lucy, Marcin Ł. Pękalski, Paula Kareclas, et al.. (2015). Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study. BMJ Open. 5(12). e009799–e009799. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026